On Monday, in the course of current trade, Shares of Baidu Inc (ADR) (NASDAQ:BIDU), dropped -1.12%, and is now trading at $ 203.58.
Baidu, declared the signing of a definitive Equity Subscription Agreement for about US$11.5 million of Series A equity for Shenzhen Qianhai VisionChina Mobile Interactive Co., Ltd.. Qianhai Mobile is a merged associate of the Company engaged in the research, development and operation of mass transit Wi-Fi networks and the provision of mobile Internet value-added services in the PRC. The transaction was led by Beijing Baidu Netcom Science Technology Co., Ltd., a merged associate of Baidu Inc. (BIDU) and also comprised of Guangdong Zhongke Baiyun New Industry Venture Investment Co., Ltd. and Dongguan Zhongke Zhongguang Venture Investment Co., Ltd., both of which are reputable national private equity investors in the PRC. The transaction is subject to customary closing conditions.
Baidu, Inc. provides Internet search services in China and internationally. It offers Chinese language search platform on its Baidu.com Website that enables users to find relevant information online, counting Web pages, news, images, documents, and multimedia files through links offered on its Website; and international products and services to users in other countries.
During an Afternoon trade, Shares of Bio-Reference Laboratories Inc (NASDAQ:BRLI), up 5.89%, and is now trading at $ 41.97.
Bio-Reference Laboratories declared its second quarter results. Except for per share data in quotations or where otherwise noted, numbers are in thousands.
The Company recorded Q2FY15 revenues of $223,986, representing an enhance of 11% over the $201,366 recorded in Q2FY14. Operating income for Q2FY15 was $18,926, up less than 1% from the Q2FY14 operating income of $18,879. Net income after taxes in Q2FY15 came in at $10,461, resulting in earnings per share of $.38, up from Q2FY14 net income after taxes of $10,273 and EPS of $.37, enhances of 2% and 3%, respectively. Gross profit on revenues for Q2FY15 was $98,983, resulting in a margin for gross profit on revenues of about 44% and a 12% improvement over the gross profit on revenues of $88,549 recorded for Q2FY14, which also resulted in a 44% margin. Revenue per patient for Q2FY15 was $86.69, an enhance of 3% from the $84.18 recorded for Q2FY14. The number of patients served raised 8% to 2,559 in Q2FY15 up from 2,364 in Q2FY14. Esoteric business for the Company was 68% of revenues for Q2FY15, the same 68% as Q2FY14. Days Sales Outstanding (DSO) was 113 days in Q2FY15 contrast to Q2FY14 when the DSO was 103 days.
Revenues for the first six months of FY15 raised to $432,820, an enhance of 13% over the revenues for the first six months of FY14 of $382,635. Operating income for the first six months of FY15 was $30,854, an enhance of 25% from first six-months FY14 operating income of $24,760. Net income after taxes for the first six months of FY15 was $17,094, resulting in an EPS of $.61, an enhance of 29% from the first six-months FY14 net income after taxes of $13,227, which resulted in an EPS of $.47. The Company stated gross profit on revenues for the FY15 first six month period of $188,738, resulting in a margin for gross profit on revenues of 44%, up from gross profit on revenues in the FY14 first six-month period of $160,703, which resulted in a margin of 42%. The number of patients served raised 7% to 4,911 in the first six months of FY15 from the FY14 same period total of 4,571. Cash flow from operations for the first six months of FY15 was a positive $10,557, contrast to a negative $188 in the FY14 same period.
Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases in the United States. The company focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional health care services.
Shares of New York Community Bancorp, Inc. (NYSE:NYCB, during its Monday’s current trading session fell 0.06%, and is now trading at $ 18.12.
New York Community Bancorp, declared that President and Chief Executive Officer Joseph R. Ficalora will take part in the Morgan Stanley Financials Conference to be held on Tuesday, June 9th, in New York.
During his presentation, which is planned to start at 1:15 p.m. Eastern Daylight Time, Mr. Ficalora will talk about the Company’s business model and its first quarter 2015 financial performance.
A simultaneous webcast of the presentation will be accessible at the Company’s website, ir.myNYCB.com. A replay of the webcast will be accessible later in the day and will be archived at the Company’s website, together with the accompanying PowerPoint slides, through June 23, 2015.
New York Community Bancorp, Inc. operates as a holding company for New York Community Bank and New York Commercial Bank that offer banking products and financial services in New York, New Jersey, Florida, Ohio, and Arizona.
Finally, Goldman Sachs Group Inc (NYSE:GS), lost -0.17% Monday, hitting its highest level.
The Goldman Sachs Group, plans to declare its 2015 Second Quarter Financial Results on Thursday, July 16th in a release that will be issued at about 7:30 am (ET).
A conference call to talk about the firm’s results, outlook and related matters will be held at 9:30 am (ET). The call will be open to the public.
The Goldman Sachs Group, Inc. operates as an investment banking, securities, and investment administration company worldwide. The company operates through four segments: Investment Banking, Institutional Client Services, Investing & Lending, and Investment Administration.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
